Gilead Sciences, Biogen and Vertex Pharmaceuticals could top expectations in an otherwise soft quarter for biotech stocks, an analyst said Thursday. He sees key products beating forecasts. Yahoo

Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance , charts, and other financial information to help you make more informed trading

This move outpaced the S&P 500's daily gain of 1.66%. Meanwhile, the Dow 2021-04-09 · Gilead Sciences (GILD) Stock Moves -0.53%: What You Should Know Gilead Sciences (GILD) closed at $64.08 in the latest trading session, marking a -0.53% move from the prior day. 3 weeks ago - Zacks Investment Research 2021-04-09 · View Gilead Sciences, Inc. GILD investment & stock information. Get the latest Gilead Sciences, Inc. GILD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 24 Wall Street analysts have issued ratings and price targets for Gilead Sciences in the last 12 months. Their average twelve-month price target is $97.23, predicting that the stock has a possible upside of 49.33%. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business.

Gilead sciences stock

Gilead Sciences Inc (NASDAQ: GILD), an American biotech company that specializes in researching, developing and commercializing drugs, has seen its stock surge after it announced the launching of GILD: Get the latest Gilead Sciences stock price and detailed information including GILD news, historical charts and realtime prices. View today's stock price, news and analysis for Gilead Sciences Inc. (GILD). Barron's also provides information on historical stock ratings, target prices, company Real-time trade and investing ideas on Gilead Sciences Inc. GILD from the largest community of traders and investors. GILEAD SCIENCES INC 0QYQ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock Price Forecast.

2 april 16:38. kommenterade Gilead Sciences, Inc. Bernstein höjer Gilead Sciences till outperform, med riktkurs 80 dollar (75). Gilla (6) Följ tråd Kommentarer (2)

Gilead Sciences, Inc. / Forbes magazine ranked Gilead its number 4 drug company, citing a market capitalization of US$113 billion and stock appreciation of 100%, and describing their 2011 purchase of Pharmasset for $11 billion as "one of the best pharma acquisitions ever". 2020-10-20 · Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-09 · GILD | Complete Gilead Sciences Inc. stock news by MarketWatch.

Gilead Sciences Inc Veränderung Vortag: -1.02%, Aktueller Kurs: 54.14 €

The 26 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 73.00, with a high estimate of 100.00 Real-time Price Updates for Gilead Sciences Inc (GILD-Q). Charting, Tear Sheets , Press, Price Performance & more. Latest Gilead Sciences Inc (GILD:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Stock Quote. NASDAQ: GILD. $65.11.

The average Gilead Sciences stock price prediction forecasts a potential downside of N/A from the current GILD share price of $66.23. 2020-02-28 10 stocks we like better than Gilead Sciences. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, 2021-01-23 1 day ago 2020-11-19 2021-03-26 Gilead Sciences market cap is $82.3 b, and annual revenue was $24.69 b in FY 2020. View Gilead Sciences stock / share price, financial statements, key ratios and more at Craft. Gilead Sciences (GILD) Stock Moves -0.53%: What You Should Know finance.yahoo.com - March 19 at 9:18 AM: Gilead Sciences, Novo Collaborate To Study Efficacy Of Cilofexor, Firsocostat In NASH Patients markets.businessinsider.com - March 18 at 9:38 AM Get today's Gilead Sciences Inc stock price and latest GILD news as well as Gilead real-time stock quotes, technical analysis, full financials and more.
Lgr11 värdegrund

Year-to-date, Gilead Sciences Inc (NASDAQ: GILD ) stock gained 17.9% and on July 14th it had a closing price of $77.19. Here is what 2020-08-11 10 stocks we like better than Gilead Sciences.

2021-03-17 · Valuing Gilead Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Gilead Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock. Gilead Sciences's P/E ratio Gilead Sciences Inc GILD Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive Sponsor Center Gilead Sciences, Inc. / ˈ ɡ ɪ l i ə d /, is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Crazy benjamin lebert

2021-04-08

Gilead Sciences har många starka motstånd. Long_BT_219_.png (614×385).

Korridorer novell

Gilead Sciences Inc (NASDAQ: GILD), an American biotech company that specializes in researching, developing and commercializing drugs, has seen its stock surge after it announced the launching of

Aktien är noterad på Nasdaq Stock Exchange som GILD .

Ystads — Att spara i ETF:er - Börskollen Gilead sciences aktie. Det är även noterat på den amerikanska börsen New York Stock Exchange.

View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 73.00, with a high estimate of 100.00 Real-time Price Updates for Gilead Sciences Inc (GILD-Q). Charting, Tear Sheets , Press, Price Performance & more. Latest Gilead Sciences Inc (GILD:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

2021-03-29 · Stock analysis for Gilead Sciences Inc (GIS:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Investor Relations website contains information about Gilead Sciences's business for stockholders, potential investors, and financial analysts. Gilead Sciences (GILD) closed at $65.23 in the latest trading session, marking a +1.94% move from the prior day. Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know - March 26 Gilead Sciences / Jubilant Life Sciences Limited enters into Licensing Agreement with Gilead for Remdesivir, a potential therapy for Covid-19 / Jubilant Life Sciences Limited enters into Licensing Agreement with Gilead for Remdesivir, a potential therapy for Covid-19 MSN 1 dag sedan · Gilead Sciences, Inc. has a market cap of $81.3 Billion and is expected to release its quarterly earnings report on Apr 28, 2021- May 03, 2021.